-
1
-
2
-
3
-
4
-
1
-
2
-
3
-
4
Clearpol's Opinion of this Guidance as of 09/09/2010
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's Summary of this Guidance

The California Department of Health has issued a new All Facilities Letter regarding the use of Interferon Gamma Release Assay (IGRA) blood tests for identifying Mycobacterium Tuberculosis infection in healthcare workers. The letter states that the use of IGRA blood tests requires a grant of program flexibility from the California Department of Public Health's Licensing and Certification Program, as the Tuberculin Skin Test (TST) is required by regulation. Facilities must submit a letter to the Licensing and Certification district office requesting program flexibility for the use of IGRA blood tests. They must also submit a policy specifying the IGRA blood test to be used in screening healthcare workers for Latent Tuberculosis Infection (LTBI), complying with current standards of practice for LTBI screening as defined by the California Occupational Safety and Health Administration. The policy must specify the group of employees in which the IGRA will be used and include a statement that employees will be informed in writing of the limitations of using IGRAs as defined by the most current recommendations by the CDC or the California Tuberculosis Controllers Association.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
You have 0 new tasks available
Below are AI generated tasks related to this document. Accept or deny a task.
Task | Deadline | Actions |
---|
No suggested tasks available at the moment!
AI generated tasks related to this document are shown here. Tasks may be coming soon or you may have accepted/denied all the available tasks for this document.
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.